Novel Baseline Quantitative MRI Relaxometry Parameters Predict Circulating Tumor DNA (ctDNA) Clearance on a Phase II HPV-Oropharynx Cancer (HPV-OPSCC) De-Escalation Study
International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e52-e53
DOI: 10.1016/j.ijrobp.2026.02.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von M. Bakhtiar und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bakhtiar, M., Guenette, J., Madore, B., Minken, J., Mukundan, D., Kaza, E., Hanna, G., Rettig, E., & Schoenfeld, J. (2026). Novel Baseline Quantitative MRI Relaxometry Parameters Predict Circulating Tumor DNA (ctDNA) Clearance on a Phase II HPV-Oropharynx Cancer (HPV-OPSCC) De-Escalation Study. International Journal of Radiation Oncology*Biology*Physics, 125(1), e52-e53. https://doi.org/10.1016/j.ijrobp.2026.02.103
Vancouver
Bakhtiar M, Guenette J, Madore B, Minken J, Mukundan D, Kaza E, et al. Novel Baseline Quantitative MRI Relaxometry Parameters Predict Circulating Tumor DNA (ctDNA) Clearance on a Phase II HPV-Oropharynx Cancer (HPV-OPSCC) De-Escalation Study. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e52-e53. doi:10.1016/j.ijrobp.2026.02.103
BibTeX
@article{Bakhtiar2026,
author = {Bakhtiar, M. and Guenette, J.P. and Madore, B. and Minken, J. and Mukundan, D. and Kaza, E. and Hanna, G.J. and Rettig, E.M. and Schoenfeld, J.D.},
title = {Novel Baseline Quantitative MRI Relaxometry Parameters Predict Circulating Tumor DNA (ctDNA) Clearance on a Phase II HPV-Oropharynx Cancer (HPV-OPSCC) De-Escalation Study},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {1},
pages = {e52--e53},
doi = {10.1016/j.ijrobp.2026.02.103}
}
EUVIMED